Research Centre | Company Search | Charting | Stock Screener | Performance Tables | Financial Diary | Investing Board
Immupharma (IMM)
Share Price: 63.25p Change Today: 2.75p  Market Cap: 78.83m

Immupharma Overview

Immupharma is in the pharma and biotech sector and is currently trading at 63.25p per share. In the last year Immupharma's share price has ranged from 23.50p to 70.32p.

1 Day Chart

6 Month Chart

Immupharma Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-11 0.02 (3.61) (4.12)p n/a n/a n/a n/a 0.0%
31-Dec-12 n/a (4.17) (4.71)p n/a n/a n/a n/a 0.0%
31-Dec-13 n/a (4.43) (4.52)p n/a n/a n/a n/a 0.0%
31-Dec-14 0.18 (3.34) (3.43)p n/a n/a n/a n/a 0.0%
31-Dec-15 0.08 (4.55) (4.40)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Immupharma Company Announcements

Holding(s) in Company 17-Feb-2017 14:04 RNS
Update on Lupuzor Phase III Study 25-Jan-2017 07:00 RNS
Change of Adviser 24-Jan-2017 07:00 RNS

Latest Immupharma Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.


Price Data

Currency UK Pounds
Share Price 63.25p
Change Today 2.75p
% Change 4.55 %
Volume 879,464
17-Feb-17 Close 63.25p
Shares Issued 124.64m
Market Cap 78.83m
Year End 31-Dec-15

Immupharma Dividends

No dividends found

Trades for 17-Feb-2017

Time Volume / Share Price
16:50 70,379 @ 63.75p
16:29 5,000 @ 63.50p
16:29 5,000 @ 63.00p
16:29 18,207 @ 63.00p
16:29 7,000 @ 62.50p

Immupharma Key Personnel

Chair Richard Warr
CEO Dimitri Dimitriou